1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Transdermal Patch Market Analysis, By Transdermal Patch Type
5.1. Introduction
5.2. Single-layer Drug-in-Adhesive
5.3. Multi-layer Drug-in-Adhesive
5.4. Reservoir
5.5. Vapor Patch
5.6. Matrix
6. Transdermal Patch Market Analysis, By Applications
6.1. Introduction
6.2. Neurologic Conditions
6.3. Pain Management
6.4. Nicotine Cessation
6.5. Cardiovascular
6.6. Others
7. Transdermal Patch Market Analysis, By Geography
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. France
7.4.3. Germany
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. Thailand
7.6.5. Taiwan
7.6.6. Indonesia
7.6.7. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. AdhexPharma
9.2. ProSolus Inc.
9.3. Tapemark
9.4. Tesa Labtec GmbH
9.5. Nitto Denko Corporation
9.6. Noven Pharmaceuticals Inc.
9.7. LTS Lohmann Therapie-Systeme AG
9.8. Medherant Limited
9.9. Corium International Inc.
9.10. Medipatch Inc.